Haisco Pharmaceutical Group: Financial Report for the first half of 2024.
Haisco Pharmaceutical Group: Notice on the additional temporary proposal and supplementary notice for the first temporary shareholders' meeting in 2024.
Haisco Pharmaceutical Group: Summary table of non-operating funds utilization and other related funds flow for the first half of the year.
Haisco Pharmaceutical Group: Announcement Regarding the Revision of the Company's Articles of Association
Haisco Pharmaceutical Group: Open solicitation of entrusted voting right report by independent directors.
Haisco Pharmaceutical Group: Announcement regarding the notice of the first extraordinary shareholder meeting in 2024.
Haisco Pharmaceutical Group: Announcement on Obtaining the Acceptance Notice for the New Indication of Innovative Drug HSK21542 Injection IND Application
Haisco Pharmaceutical Group: Announcement on the Progress of Establishing a Subsidiary in Shannan City, Tibet Autonomous Region.
Haisco Pharmaceutical Group: Notice on obtaining the “Notice of Acceptance” of the IND application for the innovative drug HSK44459 tablets
Haisco Pharmaceutical Group: Legal Opinion of Beijing Zhonglun (Shenzhen) Law Firm on the 2023 Annual General Meeting of Shareholders of Hisilicon Pharmaceuticals Group Co., Ltd.
Haisco Pharmaceutical Group: Announcement of Resolutions of the 2023 Annual General Meeting of Shareholders
Haisco Pharmaceutical Group: Notice on Obtaining an IND Application Acceptance Notice for the Innovative Drug HSK39004 Inhalation Suspension
Haisco Pharmaceutical Group: Announcement on Additional Provisional Proposals and Supplementary Notices for the 2023 Annual General Meeting of Shareholders
Haisco Pharmaceutical Group: Announcement on licensing and termination of the riluzole oral solution EXSERVAN project and preparation for impairment
Haisco Pharmaceutical Group: Notice on the establishment of a subsidiary in Shannan City, Tibet Autonomous Region
Haisco Pharmaceutical Group: Notice on amending the “Articles of Association”
HiCisco: Internal Control Self-Assessment Report
HiCisco: Announcement on the 2024 Remuneration Plan for Directors, Supervisors and Senior Management
HiCisco: Announcement on Using Idle Own Funds for Delegated Financial Management
HiCisco: Notice of Annual General Meeting of Shareholders
No Data